| Literature DB >> 32642278 |
Xuyang Peng1,2, Xi Zhu3, Zixiang Wu1, Qi Wang1, Shuai Fang1, Tianwei Zhan1, Ming Wu1.
Abstract
[This corrects the article DOI: 10.21037/jtd.2020.01.53.]. 2020 Journal of Thoracic Disease. All rights reserved.Entities:
Year: 2020 PMID: 32642278 PMCID: PMC7330794 DOI: 10.21037/jtd-2020-53
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Patient basic characteristics and postoperative clinical data
| Variable | n=206 |
|---|---|
| Age (years) | 64.61±8.12 |
| Sex (male:female) | 186:20 |
| Tumor pathology, n (%) | |
| Squamous cell carcinoma | 184 (89.32) |
| Adenocarcinoma | 12 (5.83) |
| Others | 10 (4.85) |
| Tumor location, n (%) | |
| Middle esophagus | 86 (41.75) |
| Lower esophagus | 109 (52.91) |
| Gastro-esophageal junction | 11 (5.34) |
| Prior abdominal surgery, n (%) | 27 (13.11) |
| Body mass index (kg/m2) | 21.80±2.70 |
| Tumor stage*, n (%) | |
| Stage 0/I | 42 (20.39) |
| Stage II | 75 (36.41) |
| Stage III/IV | 89 (43.20) |
| Operative time of catheter jejunostomy (min) | 10.56±2.04 |
| Postoperative hospitalization time (days) | 13.11±7.22 |
| Starting time of enteral nutrition support (days) | 1–3 |
| Retention time of jejunostomy tube (days) | 96.52±10.45 |
Data are shown as n (%) or mean ± SD. *, according to TNM staging standard of esophageal cancer in AJCC (7th edition).